Back to Search
JONATHAN RASKIN, PH.D.
PH.D.
Counseling Psychologist
NPI: 1720090541Individual
Specialties, Licenses & Credentials
Counseling PsychologistPrimary
Psychologist — Counseling
Code: 103TC1900X
013081(NY)
Research & Publications (20)
Construing stigmatized identities: a golden section study.
PMID 18334083·Psychol Psychother·2008
4-observational
Constructivism and the projective assessment of meaning in Rorschach administration.
PMID 11562099·J Pers Assess·2001
6-review
The modern, the postmodern, and George Kelly's personal construct psychology.
PMID 11330241·Am Psychol·2001
8-other
Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study.
PMID 19570122·Int J Clin Pract·2009
4-observational
Direct protein detection with a nano-interdigitated array gate MOSFET.
PMID 19501500·Biosens Bioelectron·2009
8-other
Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.
PMID 19149522·Curr Drug Saf·2009
8-other
Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder.
PMID 17588276·Int Psychogeriatr·2008
4-observational
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.
PMID 18478624·Hum Psychopharmacol·2008
8-other
Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
PMID 17311303·Depress Anxiety·2008
4-observational
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint.
PMID 18348888·J Psychiatr Res·2008
4-observational
Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder.
PMID 18204338·J Clin Psychopharmacol·2008
4-observational
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
PMID 17445831·J Psychiatr Res·2008
4-observational
The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.
PMID 17590215·Int J Clin Pract·2007
4-observational
Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
PMID 17627710·Int J Clin Pract·2007
1-meta
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
PMID 17716324·Pain Med·2007
4-observational
An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
PMID 17472422·Drug Saf·2007
1-meta
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
PMID 17472599·Psychiatry Clin Neurosci·2007
4-observational
Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies.
PMID 17474806·J Clin Psychiatry·2007
4-observational
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
PMID 17541049·Am J Psychiatry·2007
4-observational
Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
PMID 17559726·Curr Med Res Opin·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 33 EVERGREEN LN
NEW PALTZ, NY 12561 - Phone
- (845) 582-3107
Quick Facts
- NPI
- 1720090541
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile